Signalling pathways in a nutshell: from pathogenesis to therapeutical implications in prostate cancer
Open Access
- 15 May 2025
- journal article
- review article
- Published by Taylor & Francis in Annals of Medicine
- Vol. 57 (1) , 2474175
Abstract
From tumorigenesis to the establishment of local or metastatic high-grade tumours, an integral part of the cellular lifespan relies on various signalling pathways. Particular pathways that allow cells to proliferate by creating a network of new blood vessels have been documented, whereas other pathways are primarily involved with a migration to distant body parts, partially through the process of epithelial-mesenchymal transition (EMT). This review will discuss the different signalling pathways, such as TGF-β, Cripto-1, Wnt pathways, Hedgehog, Notch and NF-κB pathways, and how they promote tumour initiation and progression by influencing diverse cellular processes and EMT in general and in benign and malignant prostate tumours. This review will discuss only the critical pathways. Therefore, many other types of signalling pathways which are related to prostate cancer will not be discussed. Possibilities for further investigation will be mentioned, as many underlying mechanisms involved in these pathways have potential as targets in future tumour therapy. This review will also introduce some novel clinical trials relating to the inhibition of signalling pathways and their clinical outcomes.Keywords
Funding Information
- DRO (00098892, NW24‑03‑00265)
- Czech Ministry of Health (NU20-03-00201)
- Palacký University (LF_2025_001)
- National Institute for Cancer Research (LX22NPO5102)
- European Union ‑Next Generation EU
This publication has 153 references indexed in Scilit:
- The Hallmarks of CancerCell, 2000
- Protein kinase C is differentially stimulated by Wnt and Frizzled homologs in aG-protein-dependent mannerCurrent Biology, 1999
- The TAK1–NLK–MAPK-related pathway antagonizes signalling between β-catenin and transcription factor TCFNature, 1999
- The cyclin D1 gene is a target of the β-catenin/LEF-1 pathwayProceedings of the National Academy of Sciences, 1999
- Identification of c- MYC as a Target of the APC PathwayScience, 1998
- Beta-catenin mutations in human prostate cancer.1998
- Interaction of Wnt and a Frizzled homologue triggers G-protein-linked phosphatidylinositol signallingNature, 1997
- Structurally Related Receptors and Antagonists Compete for Secreted Wnt LigandsCell, 1997
- Tumor suppressor activity of the TGF-β pathway in human cancersCytokine & Growth Factor Reviews, 1996
- TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasmsCell, 1991